SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-17-328375
Filing Date
2017-11-01
Accepted
2017-11-01 08:31:03
Documents
2
Group Members
KERRISDALE PARTNERS MASTER FUND LTDSAHM ADRANGI

Document Format Files

Seq Description Document Type Size
1 SC 13G d480671dsc13g.htm SC 13G 52735
2 EX-99.1 d480671dex991.htm EX-99.1 7082
  Complete submission text file 0001193125-17-328375.txt   61516
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88106 | Film No.: 171167413
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1212 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1212 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (212) 792-9788
Kerrisdale Advisers, LLC (Filed by) CIK: 0001569688 (see all company filings)

IRS No.: 264757417 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G